![Pietro Scalfaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pietro Scalfaro
No más puestos en curso
Perfil
Pietro Scalfaro served as a Director on the Supervisory Board of Agendia NV, Director of Diagnoplex SA, Non-Executive Director of Biocartis SA, and Chief Medical Officer of Immunexpress Pty Ltd. He received his undergraduate degree from the University of Lausanne in 1989.
Antiguos cargos conocidos de Pietro Scalfaro.
| Empresas | Cargo | Fin |
|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Director/Miembro de la Junta | 01/04/2013 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Director Técnico/Científico/I+D | - |
Diagnoplex SA
 Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Director/Miembro de la Junta | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Director/Miembro de la Junta | - |
Formación de Pietro Scalfaro.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
21
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
- Bolsa de valores
- Insiders
- Pietro Scalfaro
